Publicaciones en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (19)

2024

  1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine

2023

  1. Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0111022

2020

  1. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey

    Mycoses, Vol. 63, Núm. 5, pp. 420-429

2019

  1. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

    Mycoses, Vol. 62, Núm. 4, pp. 310-319

2018

  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Clinical Microbiology and Infection, Vol. 24, pp. e1-e38

2017

  1. Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 4, pp. 1-3

2016

  1. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9, pp. 1-8

  2. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9

  3. Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 9

2014

  1. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26

  2. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 76-98

  3. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75

  4. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46

2011

  1. European expert opinion on the management of invasive candidiasis in adults

    Clinical Microbiology and Infection, Vol. 17, Núm. SUPPL. 5, pp. 1-12

2009

  1. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 495-507

  2. Safe living after hematopoietic cell transplantation

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 509-519

2008

  1. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Clinical Infectious Diseases, Vol. 46, Núm. 12, pp. 1813-1821

2004

  1. A European perspective on intravascular catheter-related infections: Report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 study)

    Clinical Microbiology and Infection, Vol. 10, Núm. 9, pp. 838-842

  2. Clinical-epidemiological characteristics and outcome of patients with catheter-related bloodstream infections in Europe (ESGNI-006 study)

    Clinical Microbiology and Infection, Vol. 10, Núm. 9, pp. 843-845